These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20798261)

  • 1. Matrix remodeling in vascular calcification associated with chronic kidney disease.
    Pai AS; Giachelli CM
    J Am Soc Nephrol; 2010 Oct; 21(10):1637-40. PubMed ID: 20798261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix calcification in chronic kidney disease.
    Toussaint ND
    Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):360-8. PubMed ID: 21537176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal osteodystrophy and vascular calcification.
    Arcidiacono T; Paloschi V; Rainone F; Terranegra A; Dogliotti E; Aloia A; Soldati L; Vezzoli G
    J Endocrinol Invest; 2009; 32(4 Suppl):21-6. PubMed ID: 19724162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights into vascular calcification in CKD.
    Shroff R; Long DA; Shanahan C
    J Am Soc Nephrol; 2013 Feb; 24(2):179-89. PubMed ID: 23138485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification in chronic kidney disease.
    Covic A; Kanbay M; Voroneanu L; Turgut F; Serban DN; Serban IL; Goldsmith DJ
    Clin Sci (Lond); 2010 Apr; 119(3):111-21. PubMed ID: 20443781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular calcification and hypertension: cause and effect.
    Kalra SS; Shanahan CM
    Ann Med; 2012 Jun; 44 Suppl 1():S85-92. PubMed ID: 22713153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
    Staude H; Jeske S; Schmitz K; Warncke G; Fischer DC
    Kidney Blood Press Res; 2013; 37(1):68-83. PubMed ID: 23548827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis.
    Raggi P; Giachelli C; Bellasi A
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):26-33. PubMed ID: 17180147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effects of phosphate on vascular cell function.
    Lau WL; Pai A; Moe SM; Giachelli CM
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):105-12. PubMed ID: 21406295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification.
    Bailey M; Pillarisetti S; Jones P; Xiao H; Simionescu D; Vyavahare N
    Cardiovasc Pathol; 2004; 13(3):146-55. PubMed ID: 15081471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases.
    Basalyga DM; Simionescu DT; Xiong W; Baxter BT; Starcher BC; Vyavahare NR
    Circulation; 2004 Nov; 110(22):3480-7. PubMed ID: 15545515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification.
    Bailey M; Xiao H; Ogle M; Vyavahare N
    Am J Pathol; 2001 Dec; 159(6):1981-6. PubMed ID: 11733347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness of vascular calcification alters mineral metabolism management.
    London GM
    Semin Dial; 2010; 23(3):267-70. PubMed ID: 20636919
    [No Abstract]   [Full Text] [Related]  

  • 14. Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease.
    Karamched SR; Nosoudi N; Moreland HE; Chowdhury A; Vyavahare NR
    Sci Rep; 2019 Feb; 9(1):2629. PubMed ID: 30796300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium to counteract elastin degradation and vascular calcification in chronic obstructive pulmonary disease.
    Janssen R
    Med Hypotheses; 2017 Sep; 107():74-77. PubMed ID: 28915968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of vascular calcification.
    El-Abbadi M; Giachelli CM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):54-66. PubMed ID: 17200044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease.
    Pai A; Leaf EM; El-Abbadi M; Giachelli CM
    Am J Pathol; 2011 Feb; 178(2):764-73. PubMed ID: 21281809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular calcification and arteriosclerosis in chronic kidney disease patients].
    Rodríguez Portillo JM
    Med Clin (Barc); 2009 May; 132 Suppl 1():43-7. PubMed ID: 19460480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and treatment of vascular calcification in CKD].
    Brancaccio D; Gallieni M; Pasho S; Fallabrino G; Olivi L; Volpi E; Ciceri P; Missaglia E; Ronga C; Brambilla C; Butti A; Rocca-Rey L; Chiarelli G; Cozzolino M
    G Ital Nefrol; 2009; 26 Suppl 45():S20-7. PubMed ID: 19382090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.